Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0011168 (
dysphagia
)
15,644
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A rare case of a 79-year old women with
dysphagia
and dyspnea secondary to compression of the esophagus by an aberrant right subclavian artery (
ARSA
, A. lusoria) is presented. This abnormality is generally silent and often an incidental x-ray finding. Computed tomography and intraarterial angiography, including direct catheterization of the
ARSA
, established the diagnosis. The interdependence with a co-existing coronary artery disease is discussed. Thus,
ARSA
has to be taken into account in patients with abnormal x-ray findings presenting with
dysphagia
and dyspnea.
...
PMID:Aberrant right subclavian artery (arteria lusoria) as a rare cause of dysphagia and dyspnea in a 79-year old women with right mediastinal and retrotracheal mass, and co-existing coronary artery disease. 1158 55
A rare case of a 70 years old man with
dysphagia
secondary to compression of the oesophagus by dilated aberrant right subclavian artery (
ARSA
, Arteria lusoria) is presented. Contrast enhanced computed tomography of the mediastinum in our patient revealed this anomalous vessel arising from the aortic arch distal to the left subclavian artery which passed behind the esophagus as it traveled to the right axilla. It had proximal dilated segment compressing the esophagus. The co-existence of this anomaly with aneurysm of abdominal aorta was a unique finding in our patient.
ARSA
should be taken into account in patients with
dysphagia
when more common lesions are excluded.
...
PMID:Dilated aberrant right subclavian artery (arteria lusoria), as a rare cause of dysphagia in a patient with abdominal aortic aneurysm. 1709 58
The purpose of this study was to determine whether transplantation of umbilical cord blood from unrelated donors before the development of symptoms could halt the progression of early juvenile onset cases of MLD in whom the disease was diagnosed based on the family history. Three asymptomatic children (aged 2 years 4 months, 2 years 8 months and 5 years 5 months, two of whom were sisters) underwent unrelated umbilical cord blood transplantation (UCBT) and two untreated symptomatic siblings were included in the study. In 14-year and 6-year follow-ups after transplantation, clinical examination,
ARSA
enzyme levels, neurophysiological, neuroimaging, and psychological status were assessed. All three transplanted patients remain well, and the parameters evaluated remain stable. Of the treated patients, the two sisters had ongoing evidence of demyelinating sensorimotor neuropathy on nerve conduction tests, and with a early sensorimotor neuropathy in the older sister , and the other patient has mild intellectual impairment. One of the two un-transplanted controls, 15 years after MLD diagnosis, has relentlessly progressed to full dependency with epilepsy, severe mental retardation, dystonic movements,
dysphagia
and recurrent respiratory problems. Six years after diagnosis, the other control has a slowly progressive course with spastic dystonic quadriplegia, epilepsy,
dysphagia
, continual drooling and incontinence. Our data show that, in comparison with their untreated siblings, UCBT significantly slowed the progression of the disease in the treated patients. We conclude that UCBT benefits children with pre-symptomatic early juvenile onset MLD by favourably altering the natural history of the disease.
...
PMID:Outcome of Early Juvenile Onset Metachromatic Leukodystrophy After Unrelated Cord Blood Transplantation: A Case Series and Review of the Literature. 2618 19